Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Special Organic Colloquium – Prof. Stuart Conway

"The development and targeting of epigenetic drugs for therapeutic benefit" Abstract: The talk will comprise two interconnected parts describing the development and targeting of epigenetic drugs for the treatment of disease.  The development of bromodomain ligands for the treatment of disease: bromodomains, protein modules that ‘read’ of lysine acetylation state, have emerged as important therapeutic […]

2022 M. Frederick Hawthorne Lecture

“Releasing, or capturing, that is the question. Porous molecular materials” Porous materials are one important class where the shape and distribution of “empty” space throughout the framework is a main determinant for the resulting functionality. For instance, zeolites are available with many different pore size and geometries, which is the fundament of their wide spread […]

Organic Colloquium – Prof. Ross Denton

“Phosphorus-Oriented” Method Development and Total Synthesis Abstract: The lecture will describe the design, development and applications of new synthetic methods based upon phosphorus(V) reagents and catalysts. Topics will include catalytic halogenation, hydroxyl activation and the total synthesis of polychlorinated and trimeric phenol-derived natural products.

Chem 278: Prof. James McCusker

“Ultrafast Synthesis: Leveraging Time-resolved Spectroscopy for Targeted Synthetic Control of Ultrafast Dynamics in Transition Metal-based Chromophores” Abstract: The interconversion of light and chemical energy is one of the most fundamental processes on Earth. Research on solar energy conversion, for example – which will ultimately lead to the next generation of solar energy technologies – has […]

Chem 218: Student Exit Seminar

“Choosing the right lens: Energy surfaces and chemical identity in the photodissociation of Na2+ in different solvent environments”

Special Organic Colloquium – Prof. Herman O. Sintim

Novel chemotypes of kinase inhibitors for the potential treatment of recurrent cancers Abstract: Therapeutic resistance remains a critical issue in cancer treatment. While cancer patients who harbor dysregulated protein kinases benefit from the use of kinase inhibitors (KIs), many fail therapy and almost all patients become resistant to treatment, indicating a critical unmet need to […]